ANTHIM

obiltoxaximab · Elusys Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ANTHIM, covering 2016-03-18 to 2023-07-14. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis [Phase 4]